The Wall Street Journal @WSJ

Regeneron Pharmaceuticals has won Food and Drug Administration accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma https://t.co/uOJuKJ92zD

www.wsj.com

Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.